Catching up with LGM Pharma ahead of CPhI North America to find out about its pipeline

By Liza Laws

- Last updated on GMT

© Getty Images
© Getty Images

Related tags LGM Pharma API CDMO Active pharmaceutical ingredients Active ingredient Contract manufacturing Pharmaceutical drug Supply chain

LGM Pharma is a leading CDMO provider of comprehensive API sourcing and drug product contract development and manufacturing solutions to the pharmaceutical, biotechnology, and compounding pharmacy industries.

As the company will be attending CPhI North America, OSP caught up with Hamilton Lenox, senior vice president of business development and operations.

How does your company stay ahead of industry trends and developments in the pharmaceutical sector?

LGM remains at the forefront of industry trends and developments in the pharmaceutical sector by prioritizing customer feedback and staying attuned to evolving market dynamics. By actively engaging with and listening to our customers, we continuously refine our strategies to meet their evolving needs. Our customer-centric approach serves as the cornerstone for our initiatives and investments aimed at enhancing our capabilities and expanding our services.

For instance, we've made strategic investments in standalone analytical testing services and expanded our suppository manufacturing capacity in response to emerging market demands. These proactive measures underscore our commitment to staying ahead of industry trends and ensuring that we are well-positioned to deliver tailored solutions that align with the evolving demands of increasingly complex CDMO projects.

What strategies does your company employ to ensure the quality and safety of its pharmaceutical products?

Hamilton Lenox

To ensure the quality and safety of our products, we implement a comprehensive, multi-disciplinary approach. It begins with our commitment to Quality by Design principles during formulation development, ensuring that safety and quality are built into our products from the outset. We emphasize thorough analytical method development and validation to support a robust and scalable commercial manufacturing process.

Central to our quality assurance efforts is our dedicated team of over 60 quality and analytical specialists, who bring decades of experience to their roles. They remain steadfast in their pursuit of excellence, continuously seeking opportunities for improvement. As a result, we maintain a strong regulatory track record and consistently adhere to stringent industry standards, safeguarding the integrity and safety of our pharmaceutical offerings.

Can you discuss any plans for expansion or market growth that your company has in the pipeline?

We're excited to share our latest initiatives aimed at expanding our capabilities and fostering market growth. We recently unveiled plans for a significant enhancement in our offerings: a strategic investment exceeding $2 million that expanded our standalone Analytical Testing Services (ATS) by 50%.

Our expansion efforts further extend to bolstering our suppository manufacturing capabilities. This strategic focus underscores our commitment to addressing the growing demand in key areas such as women's health, pediatric care, and geriatric medicine. By expanding our capabilities, we aim to better serve our clients' diverse needs and facilitate the development of innovative solutions tailored to their requirements.

Furthermore, we're actively investing in the augmentation of our development services, aligning equipment upgrades with commercial manufacturing needs. Our objective is to cultivate a team of scientifically adept problem solvers capable of supporting all phases of the drug development cycle, from API sourcing to finished product commercialization. Through our comprehensive analytical service offerings, we ensure complete support for our clients as their drug candidates progress through all development stages.

What sets your company apart from competitors in the pharmaceutical industry, and what value do you offer to your customers?

What sets us apart is our commitment to providing a comprehensive suite of services spanning the entire drug product lifecycle, from API sourcing to finished product commercialization. We differentiate ourselves by tailoring solutions to meet the unique needs of each client, leveraging our extensive global network of API partners to enhance efficiency and drive market success.

Our reputation for being "best in class" is evident in the trust our customers place in us, with client demand being the driving factor in our investments in new capabilities and capacity expansion. Our inherent flexibility and agility in finding creative solutions are deeply ingrained in our company culture and consistently praised by our clients. It's the dedication and expertise of our employees that enable us to consistently deliver on our promises and exceed customer expectations.

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Related suppliers

Follow us


View more